Evidence map›Paper›PMID 41322240›Full record

ArticleOpen forum infectious diseases2025

Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship.

Molly L Paras, Wendy Stead, Bismarck Bisono-Garcia, Paul S Pottinger, Rabita Aziz, Mariam Aziz, Gayle P Balba, Brian G Blackburn, Saira Butt, Brian Chow and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Molly L ParasDivision of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0001-6658-8634
Wendy SteadDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-3340-3052
Bismarck Bisono-GarciaDivision of Public Health, Infectious Diseases and Occupational Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.ORCID https://orcid.org/0000-0003-4329-4515
Paul S PottingerDivision of Allergy and Infectious Diseases, University of Washington, School of Medicine, Seattle, Washington, USA.ORCID https://orcid.org/0000-0001-9143-8857
Rabita AzizInfectious Diseases Society of America, Arlington, Virginia, USA.
Mariam AzizDivisions of Infectious Diseases and Community and Global Health Equity, Rush University Medical Center, Chicago, Illinois, USA.
Gayle P BalbaDivision of Infectious Diseases, Medstar Georgetown University Hospital, Georgetown University School of Medicine, Washington, District of Columbia, USA.
Brian G BlackburnDivision of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA.
Saira ButtDivision of Infectious Diseases, Indiana University, Indianapolis, Indiana, USA.ORCID https://orcid.org/0000-0003-3273-8379
Brian ChowDivision of HIV Medicine, Harbor-University of California Los Angeles, Los Angeles, California, USA.ORCID https://orcid.org/0000-0003-1599-9956
Christopher J GraberDivision of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.ORCID https://orcid.org/0000-0003-4041-2811
Sigridh Muñoz-GomezDivision of Infectious Diseases, New York University Grossman Long Island School of Medicine, Mineola, New York, USA.ORCID https://orcid.org/0000-0002-8836-2676
Rachael A PellegrinoDivision of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Sara SchultzSection of Infectious Diseases, Temple University Hospital, Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-0563-0752
Rachel ShnekendorfInfectious Diseases Society of America, Arlington, Virginia, USA.
Amanda JezekInfectious Diseases Society of America, Arlington, Virginia, USA.
Arlene MartinInfectious Diseases Society of America, Arlington, Virginia, USA.ORCID https://orcid.org/0009-0006-3484-1088
Vera P LutherSection on Infectious Diseases, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.ORCID https://orcid.org/0000-0002-9331-0918
Infectious Diseases Society of America Training Program Directors Community of Practice and Working Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advocacy has long been at the core of the infectious diseases (ID) field, with clinicians and researchers advocating to ensure patients can access the care they need on an individual and global scale. The Infectious Diseases Society of America Training Program Directors' (PD) Committee met in 2024 and discussed ways that advocacy is and should be incorporated into fellowship training, as well as highlighted the role PDs play in advocating for their trainees. Policies with a negative impact on ID clinical care, public health, and research underscore the importance of mobilizing the field of ID to advocate for the patients and communities we serve, as well as for ourselves. This paper presents ideas generated at this meeting and is meant to serve as a reference for ID PDs, as well as the wider ID community, as a call to action for teaching and participating in advocacy work.

Indexed as

advocacyinfectious diseases fellowshipparental leavewell-being

Identifiers

PMID41322240
PMCPMC12662047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.